MCRB - Seres Therapeutics GAAP EPS of $0.94 beats by $0.52, revenue of $0.35M
2025-11-05 07:14:15 ET
More on Seres Therapeutics
- Seres Therapeutics cuts 25% of workforce to extend cash runway into Q2 2026
- Biggest stock movers Monday: RAPP, MCRB, SATS, QS, SMMT and more
- Seeking Alpha’s Quant Rating on Seres Therapeutics
- Historical earnings data for Seres Therapeutics
- Financial information for Seres Therapeutics